Bassam Damaj

CEO at Veos Pharmaceuticals, SL

Spain · MadridJoined September 2024

Describe it (summary)

A visionary entrepreneur and stalwart in the global healthcare domain, Dr. Bassam Damaj's raison d'être lies in sculpting innovative healthcare enterprises. With a career spanning over twenty years, Dr. Damaj has solidified his reputation in the biotechnology and pharmaceutical sectors, navigating both research and commercial landscapes with well-being.

His entrepreneurial journey is punctuated by the foundation of seven trailblazing companies. Of these, three made their illustrious debut on NASDAQ, underscoring his prowess in steering startups to esteemed heights. His acumen in forging commercial collaborations is evident, with over $1 billion in partnerships with titans in the pharmaceutical and biotech arena. With a proven track record in capital mobilization, Dr. Damaj has successfully orchestrated fundraising campaigns in the US and Europe, amassing over $500 million for his ventures.

Dr. Damaj's expertise spans a comprehensive spectrum: from startup incubation, drug development, and market penetration to strategic planning, clinical operations, and investor relations. His international endeavors encompass markets such as Europe, Canada, the US, and MENA regions. He's also a virtuoso in M&A, with notable involvements in regions like US, Canada, France, Spain, and Denmark, to name a few.

Research areas of interest (7)

  • Biological Sciences
  • Biology / Biotechnology
  • Agrofood Industry
  • Technologies for the food industry
  • Consumer related
  • and 2 more

Bassam Damaj didn't publish any post yet

Bassam Damaj didn't publish any Technology Call yet

Bassam Damaj didn't publish any Technology Offer yet

Bassam Damaj didn't publish any Paper yet

Bassam Damaj didn't publish any Event yet

Bassam Damaj didn't publish any Job yet

Bassam Damaj didn't publish any New and Article yet

Bassam Damaj didn't publish any Education Resource yet

You are signed out

Join Innoget to connect with Bassam Damaj and thousands
of innovation-driven professionals and organizations